title: Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome.
abstract: The effects of bacterial endotoxin (lipopolysaccharide, LPS) are amplified by lipopolysaccharide binding protein (LBP) and CD14, resulting in cellular activation at very low concentrations of LPS. To investigate the importance of this pathway in acute lung injury, we measured LPS, LBP, and soluble CD14 (sCD14) in the bronchoalveolar lavage fluid (BAL) of 82 patients with acute respiratory distress syndrome (ARDS). LBP and sCD14 increased markedly in BAL of patients with ARDS. sCD14 and LBP each were strongly related to BAL total protein and polymorphonuclear neutrophil (PMN) concentration, whereas LPS concentration was not. Multivariate analyses showed sCD14 to be strongly related to BAL total protein, even after controlling for LPS and LBP concentrations. sCD14 was strongly and independently related to PMN concentration, after controlling for BAL LPS, LBP, and interleukin-8 (IL-8). The BAL LPS concentration was not strongly related to either BAL total protein or BAL PMN. The BAL sCD14 and LBP values were similar in all subgroups of patients with ARDS, and were not related to survival. The serum LBP and sCD14 were elevated in ARDS, but were not related to BAL total protein, LBP, sCD14, PMN, or clinical outcome. Thus, LBP and sCD14 reach high concentrations in the lungs of patients with ARDS, and BAL sCD14 is strongly related to two major indices of lung inflammation: total protein and PMN concentration. CD14-dependent mechanisms may contribute to lung inflammation in ARDS.
authors.affiliation: Medical Research Service, Seattle VA Medical Center, Seattle, Washington, 98108, USA.
authors.forename: T R
authors.initials: TR
authors.lastname: Martin
authors.forename: G D
authors.initials: GD
authors.lastname: Rubenfeld
authors.forename: J T
authors.initials: JT
authors.lastname: Ruzinski
authors.forename: R B
authors.initials: RB
authors.lastname: Goodman
authors.forename: K P
authors.initials: KP
authors.lastname: Steinberg
authors.forename: D J
authors.initials: DJ
authors.lastname: Leturcq
authors.forename: A M
authors.initials: AM
authors.lastname: Moriarty
authors.forename: G
authors.initials: G
authors.lastname: Raghu
authors.forename: R P
authors.initials: RP
authors.lastname: Baughman
authors.forename: L D
authors.initials: LD
authors.lastname: Hudson
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis*; D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D002352:Carrier Proteins / Q000032:analysis*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D018950:Lipopolysaccharide Receptors / Q000032:analysis* / Q000276:immunology; D008297:Male; D008562:Membrane Glycoproteins; D008875:Middle Aged; D015999:Multivariate Analysis; D009504:Neutrophils / Q000276:immunology / Q000502:physiology; D018410:Pneumonia, Bacterial / Q000276:immunology / Q000503:physiopathology; D011650:Pulmonary Alveoli / Q000503:physiopathology*; D012128:Respiratory Distress Syndrome / Q000276:immunology / Q000503:physiopathology*; D000099231:Lipopolysaccharide-Binding Protein
chemical_list: D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D018950:Lipopolysaccharide Receptors; D008562:Membrane Glycoproteins; D000099231:Lipopolysaccharide-Binding Protein